News
Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...
Hosted on MSN29d
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says - MSNBy Michael Erman (Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback